Pfizer Inc. Message Board

Anyone think this could happen? Glaxo is in dire need to expand it's Melanoma Research after a number of failures. ONCS market cap is only 38M. Glaxo could EASILY get ONCS for $1/share or ~ 110M

Sentiment: Strong Buy

I think LEDS is the investment here. Tons of cash. Beaten down could be a takeover name in the sector IMHO

Sentiment: Strong Buy

I think it's just a matter of time, possibly very soon, before we see more traction and a nice fert contract on West Coast. GLTA

Sentiment: Strong Buy

Maybe an alliance/partnership announcement soon also. The stock should continue higher.

Sentiment: Strong Buy

I'd be psyched in CLSN Management did this to our short friends !!

Sentiment: Strong Buy

I'm expecting some Big Buyers getting in today. Shorts have no ammunition left. Could see $9 today.

Sentiment: Strong Buy

Are they made because CLSN spoke with ROTH?

Who downgrades prior to PH3 results? Do THEY have leaked info of some sort?

Sentiment: Strong Buy

Folks that are trying to rationalize that TDOX approval is even partly factored in OR that the NDA will still need to get by FDA are just completely wrong.

The potential, upon a successful trial, will be across a broad spectrum of cancer applications. This truly is a game-changer

Sentiment: Strong Buy

Let the BIG Squeeze start. Shorts DESERVE to lose money for shorting this delivery system that WILL help cancer patients throughout the world.

Sentiment: Strong Buy

this stock is going to RIP to $30

Sentiment: Strong Buy

Who is Adam Fuerstein ? ha ha. Now that is serious reporting..dinner in the South End with a hedge fund manager that went to Harvard to study medicine. #low hanging fruit

Sentiment: Strong Buy

There is no way that large pharma won't be all over this...and quickly. They know what the potential of using TDOX is, across many lines of Cancer.

Sentiment: Strong Buy

You can see from the prints and volume that they have arrived.
Shorts are the low hanging fruit here. CLSN will be $9 today and $25 next week

Sentiment: Strong Buy

People are underestimating the valuation of Celsion upon positive results. Additionally, there are many, many shorts that will add to the squeeze. I really think we see $25-$30 with 12m 27 PFS data

Sentiment: Strong Buy

I've noticing someone is paying a nickel up....probably mean nothing except they won't trade with one of the ECN's. It might be someone using an algo as well.

Sentiment: Strong Buy

Probably will be an upgrade as well as short squeeze that will gap stock up prior to data.

Sentiment: Strong Buy

Look for an upgrade from a research firm within next two weeks. I think Celsion's stock price will hit $10 prior to data release. My expectation is it trades between $10-11 by Jan 7th. I also feel positive data will send the stock to $18. GLTA

Sentiment: Strong Buy